MacroGenics Acquired by Bora Biologics USA | Healthcare M&A Deal

Bora Biologics USA has acquired MacroGenics, a healthcare services other business in Maryland, for an undisclosed purchase price. MacroGenics operates in healthcare services, supporting CDMO and related biopharmaceutical manufacturing activities that fit Bora Biologics USA’s strategic acquisition goals. Bora Biologics USA acquisitions expand healthcare M&A capabilities in MD acquisitions by adding assets used in CDMO operations, along with associated contracts and records. The divestiture acquisition is an announced strategic acquisition by a strategic buyer, with an asset purchase agreement dated May 11, 2026 and customary closing conditions, consents, and regulatory filings.